Perelman School of Medicine

Results from the I-SPY 2 trial show that giving patients with HER2-positive invasive breast cancer a combination of the drugs trastuzumab emtansine (T-DM1) and pertuzumab  before surgery was more beneficial than the combination of paclitaxel plus trastuzumab.

After a kidney transplant, women may experience decreased kidney damage from ischemia reperfusion injury compared to men due to the impact of gender-specific hormones, suggests a new preclinical study and an analysis of patient data published online in the Journal of Clinical Investigation

Researchers at the Perelman School of Medicine at the University of Pennsylvania and other institutions have uncovered a site of genetic variation that identified which patients with Parkinson’s disease are more likely to have tremors versus difficulty with balance and walking.

A national research study to focus on diet as a tool for managing Crohn’s disease symptoms, led by James Lewis, MD, MSCE, a professor of Medicine and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania, on behalf of the Crohn’s & Colitis Foundation of America (CCFA), has been approved to receive a $2.5 million funding award by the Patient-Cent

Researchers at the Perelman School of Medicine at the University of Pennsylvania and other institutions have uncovered a site of genetic variation that identified which patients with Parkinson’s disease are more likely to have tremors versus difficulty with balance and walking.

New preclinical research provides support to a drug that has been repurposed to possibly treat a rare and extremely disabling genetic bone disease, particularly in children.

Two researchers from the Perelman School of Medicine at the University of Pennsylvania are among the recipients of the 2016 Clinical Research Achievement Award. The researchers recognized include Carl H.

How the human brain processes the words we hear and constructs complex concepts is still somewhat of a mystery to the neuroscience community.

The Fels Policy Research Initiative in the School of Arts & Sciences at the University of Pennsylvania has announced five inaugural collaborative grants for as much as $15,000 each, designed to further interdisciplinary partnerships. 

The once-a-month drug naltrexone was more effective at preventing drug relapse in ex-prisoners addicted to heroin and other opioids compared to the usual treatment modalities, including counseling and community treatment programs, according to results from a multisite, randomized trial led by researchers at the Center for Studies of Add